OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 30, 2023
CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.
March 22, 2023
The combined solutions are currently available on the market.
March 21, 2023
Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.
March 09, 2023
Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.
March 01, 2023
There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
February 24, 2023
AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.
February 02, 2023
A slew of late-stage clinical trials is expected to push new regenerative medicines onto the market in the next few years.
Improvement in viral vector yield has become integral to new cell and gene therapy product development.
December 14, 2022
Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.
October 28, 2022
The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.